(REGISTRATION NOW CLOSED)
The biological aging process is the primary risk factor for the top causes of non-accidental death in the United States, including heart disease, cancers, COVID-19, stroke, respiratory illnesses and Alzheimer’s. In total, chronic, age-driven health conditions that require ongoing medical care and treatment incur $3.7 trillion in annual healthcare spending. As people live longer, a growing proportion of our population suffer from more than one age-related condition at a time, further exacerbating the healthcare system.
Because aging is the driver of chronic diseases, therapies that directly target aging physiology could prevent or cure multiple chronic age-related diseases. Researchers in the biology of aging are beginning to understand how the biological processes of aging promote disease, and dozens of biotechnology companies are applying that understanding to delay the onset and progression of age-associated health problems. Such interventions, generally termed “longevity medicine,” have the potential to dramatically decrease both mortality and healthcare costs, likely to a greater extent than even the complete cure of any one disease, while alleviating suffering and improving quality of life — revolutionizing healthcare for all Americans.
Recognizing that there is a need for federal investment and commercialization in the longevity medicine space, the Alliance for Longevity Initiatives is hosting our inaugural D.C. Fly-In, which will include the first ever Longevity Science Briefing on March 21st, 2024. Join us for an invigorating two-day event including an intimate Q&A session with ARPA-H, the first-ever Longevity Science Briefing and an exclusive dinner with a keynote speech by Former Speaker of the House Newt Gingrich. The first ever A4LI D.C. Fly-In will set the foundation for awareness and growth for this crucial area of longevity biotechnology research and we hope to see you all there!
*Schedule subject to change
This first-of-its-kind event offers a unique opportunity to:
– Network with leading scientists and entrepreneurs to collaborate on their shared mission to extend healthy human lifespan through geroscience research.
– Create a meaningful dialogue between policymakers and scientists leading the longevity biotech industry.
– Address the importance and impact of the longevity biotech industry on Capitol Hill.
Don’t miss this chance to attend! You can secure your spot by clicking the link below. More details will be provided upon registration.
If you have further questions, please reach out to Brenda Eap at [email protected]
We hope to see you all there!
The Ritz-Carlton, Washington D.C.
1150 22nd St NW, Washington, DC 20037
Sofitel Washington DC Lafayette Square
806 15th St NW, Washington, DC 20005
Club Quarters Hotel White House, Washington DC
839 17th St NW, Washington, DC 20006
The Mayflower Hotel, Autograph Collection
1127 Connecticut Ave NW 7th Floor, Washington, DC 20036